What's in Lexaria Bioscience Corp.'s pipeline?

Lexaria Bioscience Corp. has 3 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 3 in Phase 1.

Which companies overlap with Lexaria Bioscience Corp.'s portfolio?

Top competitors by shared drug class: Amsterdam UMC, location VUmc, Assistance Publique Hopitaux De Marseille, Astellas Pharma Inc, AstraZeneca, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/lexaria-bioscience-corp.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

Lexaria Bioscience Corp. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lexaria Bioscience Corp. pipeline: 0 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 0 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Amsterdam UMC, location VUmc · 1 shared drug class
Assistance Publique Hopitaux De Marseille · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
AstraZeneca · 1 shared drug class
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders · 1 shared drug class
Beijing Chao Yang Hospital · 1 shared drug class
Beijing Dongfang Biotech Co., Ltd. · 1 shared drug class
AbbVie · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Lexaria Bioscience Corp.:

Cite this brief

Drug Landscape (2026). Lexaria Bioscience Corp. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/lexaria-bioscience-corp. Accessed 2026-06-09.